Pliant Therapeutics, Inc.
PLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746473
No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Pliant Therapeutics, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Of which not filed for Q1 2024 | Q1 2024 | Change |
|---|---|---|---|---|
| Holders | 134 | 1 | 135 | +2 |
| Shares | 62.7M | 339.2K | 65.2M | +2.81M (+4.5%) |
| Value | $1.14B | $6.14M | $971.3M | −$158.4M (−14.0%) |
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Pliant Therapeutics, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mass General Brigham, Inc | 288,690 | $4.30M | 7.53% |
| Cutter Capital Management, LP | 194,119 | $2.89M | 1.12% |
| Marshall Wace, LLP | 130,935 | $1.95M | 0.00% |
| Two Sigma Investments, LP | 107,024 | $1.59M | 0.00% |
| Renaissance Technologies LLC | 75,900 | $1.13M | 0.00% |
| Polar Asset Management Partners Inc. | 65,300 | $973.0K | 0.03% |
| Millennium Management LLC | 30,539 | $455.0K | 0.00% |
| Tudor Investment Corp Et Al | 26,897 | $400.8K | 0.00% |
| Nebula Research & Development LLC | 17,650 | $263.0K | 0.06% |
| HSBC Holdings PLC | 10,507 | $156.5K | 0.00% |
| Harbor Capital Advisors, Inc. | 8,580 | $128.0K | 0.02% |
| SG Americas Securities, LLC | 7,212 | $107.0K | 0.00% |
| Quantbot Technologies LP | 277 | $4.13K | 0.00% |
| Sofos Investments, Inc. | 19 | $290 | 0.00% |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 11 | $163 | 0.00% |
| Rothschild Investment LLC | 10 | $149 | 0.00% |
| Mine & Arao Wealth Creation & Management, LLC. | 2 | $30 | 0.00% |
| CWM, LLC | 1 | $0 | 0.00% |
Sold out (16)
Institutions that held Pliant Therapeutics, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Exome Asset Management LLC | 49,580 | $897.9K |
| Balyasny Asset Management LLC | 37,143 | $672.7K |
| HRT Financial LP | 28,430 | $514.0K |
| Mirae Asset Global Investments Co., Ltd. | 27,363 | $495.5K |
| Prelude Capital Management, LLC | 21,509 | $389.5K |
| State Board of Administration of Florida Retirement System | 16,180 | $293.0K |
| Landscape Capital Management, L.L.C. | 16,146 | $292.4K |
| Oppenheimer & Co Inc | 10,877 | $197.0K |
| Teacher Retirement System of Texas | 10,232 | $185.0K |
| West Tower Group, LLC | 4,701 | $85.1K |
| Caption Management, LLC | 4,000 | $72.4K |
| Cutler Group LP | 900 | $16.0K |
| EverSource Wealth Advisors, LLC | 59 | $1.07K |
| Lindbrook Capital, LLC | 50 | $906 |
| Harbour Investments, Inc. | 25 | $453 |
| Cornerstone Planning Group LLC | 2 | $36 |
Not filed for Q1 2024 yet (1)
Institutions that held Pliant Therapeutics, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| TRV GP III, LLC | 339,160 | $6.14M |